PCN176 - A COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB VERSUS DOCETAXEL FOR PREVIOUSLY TREATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN BELGIUM
K. Moeremans
◽
L. Van Bellinghen
◽
T. De Celle
◽
B. Quintens
◽
N. Paracha
B. Pinheiro
◽
L. Silva Miguel
◽
J. Alarcão
◽
N. Paracha
◽
F. Felizzi
◽
...
2019 ◽
Vol 40
(2)
◽
pp. 129-137
◽
Qiao Liu
◽
Xia Luo
◽
Liubao Peng
◽
Lidan Yi
◽
Xiaomin Wan
◽
...
A. Tetafort
◽
H. Haug
◽
C. Le Péchoux
◽
C. Chouaid
◽
A. Gherardi
◽
...
Yong-Jin Kim
◽
Mark Oremus
◽
Helen H. Chen
◽
Thomas McFarlane
◽
Danielle Fearon
◽
...
2019 ◽
Vol Volume 11
◽
pp. 9195-9202
◽
Maobai Liu
◽
Longfeng Zhang
◽
Qishu Huang
◽
Na Li
◽
Bin Zheng
◽
...
Brendan T. Heiden
◽
Joshua D. Mitchell
◽
Eric Rome
◽
Varun Puri
◽
Bryan F. Meyers
◽
...
2019 ◽
Vol 18
◽
pp. 1-7
◽
Xinyan Li
◽
Weichen Li
◽
Lingping Hou
Xuan Chen
◽
Zhiguang Yang
◽
Guiyuan Xiang
◽
Lingna Gu
◽
Ziheng Qi
◽
...
2006 ◽
Vol 13
(2)
◽
pp. 109-126
◽
Daniel R. Touchette
◽
J. G. Stevenson
◽
Gail Jensen
2019 ◽
Vol 22
(4)
◽
pp. 344-349
◽
Weiting Liao
◽
Jiaxing Huang
◽
David Hutton
◽
Qiu Li
Close
Export Citation Format
Close
Share Document
Close